SNDL - SNDL Inc.
NEXT EARNINGS:
Mar 12, 2026
(in 15 days)
EPS Est: $0.01
|
Rev Est: $258.0M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$3.95
DETAILS
HIGH:
$5.00
LOW:
$3.25
MEDIAN:
$3.60
CONSENSUS:
$3.95
UPSIDE:
154.84%
Market Cap:
399.12M
Volume:
831,253
Avg Volume:
2,721,580
52 Week Range:
1.15-2.89
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.73
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
CA
Employees:
2,604
IPO Date:
2019-08-01
EPS (TTM):
-0.38
P/E Ratio:
-7.17
Revenue (TTM):
920.45M
Total Assets:
1.35B
Total Debt:
152.27M
Cash & Equiv:
218.36M
Rev Growth (5Y):
70.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-7.8%
Debt/Equity:
0.13
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $-0.04 | $-0.00 | -11011.1% | $175.1M | $258.0M | -32.1% |
| 2025-07-31 | $0.01 | $-0.04 | +125.0% | $179.7M | $243.0M | -26.1% |
| 2025-05-01 | $-0.04 | $-0.06 | +33.3% | $143.9M | $243.3M | -40.9% |
| 2025-03-18 | $-0.19 | $-0.01 | -1800.0% | $179.1M | $204.1M | -12.3% |
| 2024-11-05 | $-0.05 | $-0.04 | -40.0% | $174.6M | $248.1M | -29.6% |
| 2024-08-01 | $-0.01 | $-0.04 | +75.0% | $166.9M | $168.9M | -1.2% |
| 2024-05-08 | $-0.01 | $-0.04 | +75.0% | $145.6M | $180.2M | -19.2% |
| 2024-03-20 | $-0.22 | $-0.12 | -83.3% | $187.1M | $182.6M | +2.4% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 920.45M | 909.01M | 712.20M | 56.13M | 60.92M | 63.56M | 9.65M | 0 |
| Net Income | (94.80M) | (172.66M) | (335.11M) | (226.98M) | (233.25M) | (271.46M) | (12.99M) | (1.55M) |
| EPS | -0.38 | -0.65 | -1.50 | -1.24 | -9.50 | -31.78 | -8.50 | -0.18 |
| Total Assets | 1.35B | 1.47B | 1.56B | 1.43B | 294.87M | 510.04M | 25.75M | 12.67M |
| Total Debt | 152.27M | 167.03M | 169.83M | 33.47M | 1.44M | 211.09M | 7.14M | 25,564 |
| Cash & Equivalents | 218.36M | 195.04M | 279.59M | 558.25M | 60.38M | 45.34M | 7.68M | 3.72M |
| Operating Cash Flow | 54.91M | (16.65M) | (6.71M) | (155.44M) | (57.49M) | (112.74M) | (5.25M) | (1.40M) |
| Free Cash Flow | 43.90M | (24.58M) | (17.57M) | (159.23M) | (60.67M) | (223.01M) | (12.83M) | (6.18M) |
| FCF per Share | 0.17 | -0.09 | -0.08 | -0.86 | -2.77 | -26.01 | -1.53 | -0.74 |
| Book Value | 1.13B | 1.21B | 1.31B | 1.33B | 271.68M | 216.48M | 13.71M | 11.52M |
| Cash & ST Investments | 248.89M | 201.64M | 311.76M | 649.03M | 60.38M | 45.34M | 7.68M | 3.72M |
| ROC Equity | -0.08 | -0.14 | -0.26 | -0.17 | -0.86 | -1.25 | -0.95 | -0.13 |